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Abstract 
Dilantin (DPH) is the most commonly prescribed anticonvulsant drug used today, 
but it is also known to be a human teratogen. Previous studies on the effects of DPH 
using NSA mice have revealed detailed information on the specific mechanisms of 
embryo development that are directly affected by DPH potentially causing the collection 
of fetal abnormalities termed fetal hydantoin syndrome (FHS}. It has been shown that 
the cell cycle is deregulated in preimplantation mouse embryos treated with DPH by 
altering the expression of cyclin A. Even more, the DNA polymerase 8 (Pol 8) protein 
catalytic subunit has been shown to have a decreased expression contributing to 
delayed DNA synthesis in 2-cell mouse embryos. This study continues the analysis of the 
DNA Pol 8 subunit by beginning to examine the effect DPH has on the expression of Pol 
8 mRNA. This would explain whether Pol 8 protein levels are being affected at the level 
of mRNA expression or later on at protein synthesis or a period beyond that. RT-PCR, gel 
electrophoresis, and ethidium bromide UV-fluorescence imaging were used as tools to 
examine the relative levels of expression of Pol 8 mRNA of DPH and NaOH treated 2-cell 
mouse embryos at GlandS phase of the second cell cycle. The results of this study 
were inconclusive in terms of determining the effect of Dilantin on Pol 8 mRNA 
expression . However, the proper primers for Pol 8 were designed, and the 
concentrations of MgS04 and the primers were both optimized at 2mM and 0.125mM 
respectably. The next step would be to isolate more embryos and run reactions at these 
optimal levels to determine the effect of DPH on Pol 8 mRNA expression. 
2 
Acknowledgments 
I want to thank Dr. Clare Chatot for welcoming me into her lab when no other 
research professor in the Biology or Chemistry departments would. She has been an 
awesome advisor for me during my entire time here at Ball State and especially helpful 
and supportive during this thesis work. 
I want to thank my high school advanced biology teacher, Mr. John Wallace, 
whose excellent teaching skills and great love of biology jumpstarted me down this path 
in the sciences. 
I want to thank my family, especially my parents whose hard work and loving 
support has guided (and funded) me through all of my schooling allowing me to explore 
the world of science and get a great education. 
I want to thank my advisors, professors, classmates, and friends, especially Cruz 
Aleman, Michael Gasper, Elise Hoff, and Emma Mappes for being good friends and all 
around great people to be around these last few years. 
I also want to thank all of the men and women at the St. Francis Newman Center, 
especially Kenny Cavanaugh, Tommy Behan, Ben Cepican, Zane Langenbrunner, Austin 
Frey, and Andres Nieto, who have been great role models and friends of mine while 
studying at Ball State. They have kept me grounded and helped me always remember 
where my priorities should be. 
3 
Table of Contents 
Abstract .... ........... .......................... .. ... .... ..................... 2 
Acknowledgments ..... ......................... .... ........ ... ....... 3 
Table of Figures ................ ... ................................ ... ..... S 
Project Analysis Statement ... ......... ............................ 6 
Introduction .. ... .... ... ......................................... ........... . 8 
Literature Review ................. ... ....... ............................ ll 
Materials and Methods ......................................... .. . 19 
Results/Discussion ............................. ....... ... ...... ....... 26 
Bibliography ........ ................................................. .. ... 33 
CITI Certification ........................ ... ............................ 36 
4 
Figure 1 
Figure 2 
Figure 3 
Figure 4 
Figure 5 
Figure 6 
Figure 7 
Figure 8 
Table of Figures 
2-D Chemical structure of DPH and metabolic by-products 
Preimplantation Mouse Embryo Developmental Stages 
DNA polymerases a, 8, £, and ~subunit structures 
Representations of the traditional (standard fork) and the 
new model (Alternate fork) of DNA replication 
Effect of primer concentration on Pol 8 mRNA expression in Mouse 
Liver 
Effect of MgS04 concentration on Pol 8 mRNA expression in Mouse 
Liver 
Effect of primer concentration on Pol 8 mRNA/ GAPDH expression in 
Mouse Liver. 
Effect of primer concentration on Pol 8 mRNA expression in 2-cell G1 
phase NaOH vehicle Mouse embryos 
13 
15 
16 
17 
27 
28 
29 
36 
5 
Project Analysis Statement 
This project has taken place during a very interesting pivot in my college career. 
Over the past 6 months, my goals have opened back up from the medical school tunnel 
vision I was experiencing. It is no longer clear to me if I will be going to medical school 
and preparing for work as a physician or getting a viticulture master's degree and 
working a grape farm and winery. Fortunately, should I pursue a vintner career instead 
of pursuing medical school, experience working in a biology research lab will still be 
advantageous. 
The idea for th is project was simply a product of necessity. During my entire time 
here at Ball State I have been doing anything and everything I can to make myself 
competitive for a spot in any medical school that would accept me. One of these things 
was getting involved with a research lab. So during the spring of sophomore year after 
being rejected from the chemistry department's summer research program, I contacted 
every biology professor with a research lab and Dr. Chatot responded with an invitation 
to get involved with her lab. Her lab was exploring the effects of an anti-seizure drug, 
Dilantin, on two things: sperm/egg interactions, and fertilized embryo development. I 
chose to work on the fertilized embryo project. A previous master's st udent who had 
completed her thesis in this lab essentially paved the way for the inquiry I would be 
making with my work. To prepare for this work, I was required to be certified in handling 
animals in a scientific research setting, so I spent that summer acquiring this 
certification through the collaborative institut ional t ra ining initiative, CITI. The next step 
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of preparation was studying the mouse development in more detail as well as the 
details of designing and conducting a proper PCR protocol. Dr. Chatot taught me how to 
find PCR primer pairs specific to our species and target gene on a massive database. The 
last background work to be completed was my literature review. This task required me 
to review a large number of research articles pertaining to this work. Fortunately, the 
previous papers coming from this lab provided me with a good place to start. 
What the completion of this project during this luminous time has taught me is 
to see things through no matter the changes in motivation. With this project being the 
most integrating of different bodies of knowledge that I have ever had to do, I feel this 
project helped me gain confidence in myself and in the knowledge and skills I have 
obtained during my time at Ball State. 
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INTRODUCTION 
Dilantin is one of several-marketed antiepileptic drugs used in the treatment of 
seizures and several behavioral disorders. Women suffering from seizures who are being 
treated with antiepileptic drugs are advised to continue their treatment during 
pregnancy. Antiepileptic drugs are known to cause a variety of birth defects in the 
children of mothers taking these drugs during pregnancy. The collection of defects 
related to the use of Dilantin is called Fetal Hydantoin Syndrome {FHS) {Oguni and 
Osawa, 2004). FHS is characterized by multiple developmental and growth related 
abnormalities such as craniofacial abnormalities, cleft lip and palate, microcephaly, and 
limb deformities {Hanson and Smith, 1975). It is thought that the cause of these defects 
is related to the oxidative metabolic byproducts of these drugs produced in vivo by the 
fetus that disrupt many different mechanisms of embryogenesis {Wlodarczyk, 2012). 
The metabolism of DPH has been studied in other mammalian species besides 
humans including rats {Dill et al., 1956), and mice (Chow & Fischer, 1982). The 
teratogenicity of DPH has been extensively studied in Mouse embryos (Sullivan and 
McElhattan, 1975), which have been the species of choice in the Chatot lab (Blosser and 
Chatot, 2003). In one study by Aide Cornielle-Dipre in the Chatot lab, it was discovered 
that Dilantin negatively effects the expression of the protein for DNA polymerase o (Pol 
o), a polymerase that functions in DNA replication along both the leading and lagging 
strand to elongate initiated DNA replication forks (Pavlov and Shcherbakova, 2010). 
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Using immunofluorescence with confocal microscopy, a 50% reduction in Pol o protein 
was seen in the G1 phase of the second cell cycle in DPH treated embryos compared 
with NaOH vehicle control embryos. Interestingly there was no observed Pol o protein 
reduction in 2-cell stageS phase DPH treated mouse embryos {Corn ielle-Dipre Master's 
Thesis, 2010). In another study by Tolliver in the Chatot lab (Tolliver Master's Thesis, 
2013), it was shown that DPH negatively affected the rate of DNA synthesis. The rate of 
synthesis was slowed in DPH treated embryos, which was measured at different time 
points. In a kinetics study, there was an 85% reduction in DNA synthesis rate for the first 
5 minutes in DPH treated 2-cell S phase embryos in comparison to NaOH vehicle 
controls, a 20% reduction in rate in the first ten minutes, and an overall 31% reduction 
in rate over the entire 40 minutes of data collection. It is thought that this effect on DNA 
synthesis is due to a reduction in the expression of cyclin A and Pol o {Tolliver and 
Chatot, 2013}. The observed DPH induced reduction in cyclin A could reduce the rate of 
Polo function since cyclin A is needed for progressive replication fork elongation while a 
reduction in Pol o concentration would reduce the number of functional replication 
forks elongating at any given time {Bashir et al., 2000). The causes of the reduction in 
Polo concentration are unknown. There may be a disruption in the mRNA expression 
that leads to lower Polo protein production, or the disruption could be in the Pol o 
protein production itself. 
In order to examine the effects of Dilantin on Polo mRNA expression, this study 
used gene-specific primers in an RT-PCR reaction t o amplify the Pol o RNA present in 
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preimplantation mouse embryos treated with DPH or NaOH vehicle in vivo. Determining 
the levels of amplified RNA for Polo in embryos at GlandS phases of the second cell 
cycle would allow for evaluation of the relationship between Dilantin induced reduction 
in Polo protein and Polo mRNA expression. 
The hypothesis for this study is that Dilantin will reduce the mRNA expression of 
DNA polymerase o during G-1 and S phase of the second cell cycle in pre-implantation 
mouse embryos thus altering the elongation phase of DNA synthesis. This work 
concentrated on the design and optimization of RT-PCR for amplifying Pol o RNA in 
control liver tissue and in Gl NaOH control embryos. 
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LITERATURE REVIEW 
Dilantin Metabolism and Fetal Hydantoin Syndrome 
Anticonvulsant drugs are widely used among pregnant women with 1 out of 
every 200 women taking these drugs during their pregnancy. These drugs are known to 
be associated with birth defects. Dilantin (DPH) is the most widely used anticonvulsant 
drug. The pattern of birth defects associated with the use of DPH during pregnancy is 
termed Fetal Hydantoin Syndrome (FHS). FHS is characterized by craniofacial 
abnormalities, cleft lip and palate, microcephaly, limb deformities, neurological defects, 
deficiencies in vitamin K and D, and cardiac defects (Hanson and Smith, 1975). The rate 
of birth defects among babies born to mothers taking an anticonvulsant drug is 2 to 3 
times higher than the normal rate across the United States (Fitzgerald, 2004). 
The teratogenic effects of DPH are understood to be a result of the metabolic 
byproducts that are formed during the bioactivation of DPH (Figure 1a) (Buehler et al., 
1990). The most important byproduct is an arene oxide (Figure 1b) that is produced by 
the cytochrome P-450 monooxygenase pathway (Strickler et al., 1985). This arene oxide 
is an epoxide, which is an especially reactive compound due to its oxygen bridge. The 
oxygen bridge allows for covalent binding to embryonic macromolecules resulting in 
damage to DNA, RNA, and protein, which leads to a high risk of development 
abnormalities. 
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There is an enzyme, epoxide hydrolase, that can inactivate the reactive epoxide 
via hydrolysis making the byproducts, p-Hydroxy Phenytoin, m-Hydroxy Phenytoin, and 
Phenytoin Dihydrodiol soluble and removable from the body via the kidneys. It has been 
proposed that there are two alleles for the gene that encodes the epoxide hydrolase 
enzyme, fast and slow. The risk of developmental abnormalities depends on the fetus 
inheriting two slow isoforms resulting in an inability to quickly remove the epoxide 
before damage is done (Buehler et al., 1990) resulting in teratogenesis. 
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Figure 1. 2-D Chemical structure of DPH and metabolic by-products. Cytochrome P450 
metabolizes a. phenytoin into b. phenytoin arene oxide or c. water-soluble diphenyl 
hydantoic acid. Epoxide hydrolase breaks down the phenytoin arene oxide to d. p-hydroxy 
phenytoin, e. m-hydroxy phenytoin or f . phenytoin dihydrodiol. (Chatot lab) 
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Preimplantation Mouse Embryo Development 
Preimplantation mouse embryo development starts at fertilization of the mouse 
embryo in the ampulla of the oviduct (Sakkas and Vassalli, 2008). After fertilization, the 
embryo does not implant for four days while it travels down the oviduct to reach the 
uterus where it implants. The fertilized embryo goes from 1-cell to 32-cells during the 
first 3 and half days of this 4-day journey. The 1-cell embryo (Figure 2A) spends about 24 
hours in the cell cycle, G1 is 3-8 hours long, S phase is 6 hours, and G2/M phase is 6 hours 
long (Krishna and Generosa, 1977). In the second cell cycle (2-cell embryo) (Figure 2B), G1 is 
1.3 hours, S phase is 6.1 hours and 15.4 hours for G2/M phase for a total of 22.8 hours 
(Sawicki et al., 1978). During the middle of the 2-cell stage, the zygotic genome is activated 
switching the control of protein synthesis from the mother to the embryo (Pika and Clegg, 
1982). The switch to embryo-controlled development makes the second cel l cycle longer 
than a normal cell cycle, and can extend as long as 30 hours (Sakkas and Vassalli, 2008). 
During the 8-cell stage, the cell junctions become more integrated and boundaries 
disappear in a process called compaction (Figure 2C). At the 16-cell stage, the distinction is 
made between inner and outer cells forming the morula (Figure 2D). These populations 
expand during the blastocyst stage as the embryo prepares to implant in the uterus. The 
inner cells will become t he fetus while the outer cells will integrate with the uterus forming 
the chorionic portion of the placenta (Gilbert, 2010). The current study will focus on the 2-
cell stage (Figure 2 B) of development in G1 and S phases. 
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Figure 2: Preimplantation Mouse Embryo Developmental Stages. One-cell stage 
A., Two-cell stage B., Post-8 cell stage C., Morula stage D., Blastocyst E. 
DNA Polymerases 
DNA polymerases are enzymes that maintain the genome by performing DNA 
replication during cell division, by repairing damage to new DNA as well as bypassing 
damaged DNA during synthesis. All DNA polymerases share the same conformational 
structure similar to a human right hand with a palm, thumb, and fingers (Hubscher et 
al., 2002). There are many different types of DNA polymerases that are grouped into 
families based on their sequence and structure similarities. Polymerases a, l5, and E 
make up the B family because they are all eukaryotic enzymes that function in DNA 
replication. Besides Poll5, the other polymerases have their own role to play in DNA 
replication such as polymerase a that initiates the replication forks and polymerase E 
that is traditionally thought to elongate the leading strand. These enzymes are each 
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made of a large subunit with severa l smaller subunits that function to maintain the large 
subunit. 
Pol 8 is made of four subunits. The p125 subunit is the larger catalytic subunit as 
seen in Figure 3. Then there are the pSO, p66, and p12 subunits that all have their own 
role. The pSO subunit functions in maintaining the structure of the p125 subunit and 
stabilizes the p66 subunit. The p66 subunit functions in proliferating cell nuclear antigen 
interaction. This subunit is associated with regulating error-prone trans-lesion synthesis. 
The p12 subunit functions in protein-to-protein interactions during replication, but the 
mechanisms are not well understood (Pavlov and Shcherbakova, 2010) . 
Pol a I Prtmase Pol o 
PolE Pol~ 
Figure 3. DNA polymerases a, 6, £, and ~subunit structures 
(From Waisertreiger et al., 2012) 
The role of Pol 8 is to elongat e and coordinate the synthesis along both leading 
and lagging strands of DNA from the RNA primer. This understanding of Pol 8 changes 
the traditional replication fork model to an alternate model as seen in Figure 4. In the 
traditional st andard fork model, Pol 8 elongates along the lagging st rand via Okazaki 
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fragments while polymerase E, (Pol E) elongates along the leading strand. It has been 
shown in yeast that when PolE is damaged, replication can still continue, but when Polo 
is damaged, replication is stopped. This was thought to indicate that Polo was taking 
over for PolE when it could not properly function. Further experimentation revealed 
that Polo more likely elongates along both strands normally rather than just taking over 
the leading strand elongation when Pol E is failing. (Pavlov et Shcherbakova, 2010). 
Standard Fork Alternate Fork 
Figure 4. Representations of the traditional (Standard Fork} and the 
new model (Alternate Fork} of DNA replication. (From Burgers, 2009) 
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Significance 
This study will add to the growing understanding ofthe specific mechanisms 
behind the teratogenic effects of anticonvulsant drugs by defining conditions to 
evaluate potential effects of DPH on Pol 6 RNA expression, Better understanding of the 
functions disrupted by DPH in embryos could potentially aid in the development of 
better anticonvulsant drugs in the future that do not place pregnant women at as high 
of a risk of having children with birth defects. 
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MATERIALS & METHODS 
DNA Polymerase o is the enzyme used for the elongation of DNA during the 
replication process. Prior studies in the Chatot Lab have indicated that the protein for 
this DNA Polymerase is reduced in the mouse embryo during second cell cycle G-1 phase 
but not inS phase. This reduction could be due to reductions in mRNA concentration or 
in protein synthesis levels or to an increase in protein degradation. This study will 
address the question of whether DPH treatment alters levels of mRNA for the catalytic 
subunit of DNA Polymerase o. 
The goals of this study were to: 
1. Design primers to allow for the amplification of mRNA for DNA Polymerase 6. 
2. Optimize conditions using mouse liver extract to allow the use of the primers 
in an RT-PCR reaction to amplify mRNA for DNA Polymerase 6. 
3. Use RT-PCR to determine iftreatment with DPH alters the expression of 
mRNA for DNA Polymerase 6 in embryos isolated at G1 and S phase ofthe 
second cell cycle in comparison to NaOH vehicle controls. 
Primer Design 
Using the NCBI primer-BLAST tool, several primers were designed to be used for 
amplifying the POLD1 gene that codes for the expression of the DNA polymerase o p125 
catalytic subunit. The primer set that was chosen to be used for the experiment was 
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determined based on specificity for the POLDl gene. Primers with especially high 
specificity would lower the chances of getting contaminating non-specific DNA/RNA 
amplification and primer dimers. For POLDl, the 5' oligonucleotide sequence was 5'-
TACCTCATCTCTCGGGCACA-3' and the 3' sequence was 3'-CTGTGCTGAACGTCCTCCTT-5' . 
The primers were chosen for their optimal GC content, which was 55%; their Tm values 
of 60.03 and 59.97 °C; their low self-complementarity scores of 2.00 and 4.00 
respectively and the lack of 3' complementarity. To avoid unnecessary mismatches, GC 
content should remain between 40-60%, Tm values should be close together and self-
complementarity low. Finally, there were only 2 other gene targets for these primers; a 
skeletal muscle myosin heavy chain variant and a myc induced nuclear antigen gene 
with product sizes of 1961 and 1296 bp respectively. Both are unlikely to be expressed 
in the 2-cell embryo. 
Liver RNA Isolation 
To ensure the selected primers amplified the target gene for polymerase 6, a 
positive control RNA was made using RNA isolated from liver tissue from female NSA 
mice using a Promega SV-Total RNA isolation system. The mice were sacrificed via 
cervical dislocation and portions of liver ti ssue were removed and placed in petri dishes 
containing lOX PBS. The tissue was blotted and weighed and 150 mg was placed in a 
tissue homogenizer with a Teflon pestle with the addition of 1300 Ill of RNA lysis buffer, 
which denatures proteins including RNases that would otherwise degrade the RNA to be 
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isolated. After homogenizing the tissue, 175 Ill of the solution was aliquoted into each 
of 4 fresh microcentrifuge tubes with the addition of 350 Ill of dilution buffer to 
precipitate cellular debris and dissolve the RNA. After inverting the tubes several times, 
the tubes were heated at 70 °C for 3 minutes. The tubes were then centrifuged for 10 
minutes at 14,000 X g to collect the precipitated debris into a pellet. The supernatant in 
each tube containing DNA and RNA was removed and placed in fresh tubes with the 
addition of 200 Ill of 95% EtOH to precipitate the nucleic acids out of solution. After 
inverting the tubes several times, the tubes w_ere transferred to fresh spin columns and 
centrifuged for 1 minute at 14,000 X g to trap the precipitated DNA and RNA in the 
basket matrix. After discarding the collection tube liquid, 600 Ill of RNA wash solution 
was added to the spin baskets and spun down for 1 minute at 14,000 X g. The baskets 
were then treated with 50 Ill of DNase solution for 15 minutes to break down any 
contaminating DNA before the addition of 200 Ill of DNase stop solution to each basket 
and spun down for 1 minute at 14,000 X g to remove the dissolved degraded DNA from 
the column matrix. In order to purify the column of any remaining salts, proteins, and 
cellular debris a series of washes was performed starting with 600 Ill of RNA wash 
solution being added and baskets being spun down for 1 minute at 14,000 X g. The 
collection tubes were emptied, and an additional 250 Ill of RNA wash solution was 
added to the baskets and spun down for 2 minutes at 14,000 X g to remove the 
maximum amount of wash buffer. The baskets were transferred to new collection tubes 
where 100 Ill of Nuclease-Free water was added and spun down for 1 minute at 14,000 
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X g to elute the RNA from the matrix into solution. The baskets were discarded and the 
RNA solutions were combined in a fresh microcentrifuge tube. A 1:100 dilution of 
sample was made from a portion of the RNA solution and analyzed in a 
spectrophotometer obtaining O.D. 260/280 readings to determine concentration and 
purity of the isolated RNA. The main solution was aliquoted into several PCR tubes for 
individual RT-PCR reactions and stored at -80 °C. 
Embryo Isolation 
Female NSA mice {internal breeding colony; original stock from Envigo, 
Indianapolis, IN) were superovulated with 10 IU of Pregnant Mare Serum 
Gonadotrophin {PMS) followed 48 hours later with 5 IU of human Chorionic 
Gonadotrophin {hCG). Females were mated immediately following hCG injection with 
B6SJLF1/J males {Jackson Laboratories, Bar Harbor, ME). Pregnant female NSA mice 
were treated with 55 mg/kg Dilantin dissolved in 0.001 N NaOH {dissolved to give the 55 
mg/kg dose in 0.1 ml per 10 g of body weight) or with a comparable volume per body 
w eight of 0.001 N NaOH as the vehicle control by intraperitoneal injection at 9:00AM 
on the morning following mating. 
NSA pregnant female mice were sacrificed by cervical dislocation {BSU approved 
IACUC protocol# 91855) at time points that would ensure the collection of embryos at 
GlandS phase of the second cell cycle; i.e. 11 PM of the day after mating for 2-cell G1 
and 3 AM of the day following mating for 2-cell S phases. If embryos had not yet 
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reached the 2-cell stage at the first isolation time point, the embryos were saved as 1-
cell G2/M embryos. For embryo isolation, the oviducts were removed from the mice, 
washed in 0.9% saline, transferred to Hank Balanced Salt Solution with BSA (HBSS+BSA) 
and the embryos were flushed from the oviduct. Embryos were washed 3 times in HBSS 
+BSA and transferred to CZB medium without glucose. Embryos at G2/M 1-cell, G1 2-
cell or S 2-cell phases were each transferred in random groups of 10 to 0.5 ml PCR tubes 
in 2 111 of CZB medium. One microliter of RNasin was added to each tube to prevent 
RNA degradation in storage and 10 11L of nuclease free water was added to lyse the 
embryo cells. Aliquots were frozen at -80 °( until use in RT-PCR. 
RT-PCR Protocol for Embryo and Liver RNA 
RT-PCR reactions were conducted on samples of Liver RNA and lysed mouse 
embryos using the Promega Access RT-PCR kit. Polymerase 8 and GAPDH mRNA 
sequences were amplified. Due to a consistent expression of GAPDH in all mouse tissue, 
these sequences were amplified for an endogenous control. 
To ensure optimal amplification of the target sequences and reduction of primer 
dimerization, several optimization experiments were conducted on both the liver tissue 
and mouse embryos. A magnesium curve experiment was done for both liver and 
embryo samples to determine optimal levels of MgS04 to use in the RT-PCR reactions 
for both samples using the POLD1 designed primer. Primer curve experiments were also 
completed in the same manner to determine the optimal primer concentration to use in 
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the RT-PCR reactions. GAPDH primers were run in the same reaction tubes with the 
POLDl primers as a positive control. These primers were run through an optimization 
curve also, but the band sizes for the GAPDH (289 bp) and POLDl (263 bp) primers were 
too similar to differentiate. GAPDH primers were then run in their own reaction tubes 
with each POLDl experiment using the same reaction mix to maintain the necessary 
positive control without interfering with the analysis of the POLDl band patterns. For 
GAPDH primers, the 5' sequence was 5'-GCATGGCCITCCGTGITCCT-3' and the 3' 
sequence was 3'-CCCTGITGCTGTAGCCGTAITCAT-5'. 
The positive control tubes contained 10 ~L of AMV /Tfl SX reaction buffer, 1 ~L 
dNTP mix, 4 ~L Mg$04, 1 ~g mouse liver RNA, and 1.0 ~L of AMV reverse transcriptase 
and Tfl polymerase. The Tfl polymerase was added to each tube after the PCR machine 
reached the 94 °( denaturation temperature constituting a "Hot-Start" to minimize 
primer dimerization. In the negative control tube, nuclease-free water was added in 
place of the RNA sample. 
The reaction tubes containing the mouse embryos differed in respect to the 
amounts of primers and Nuclease-free wat er added, but everything else was maintained 
the same including the total reaction volume of 50 ~L. 
The parameters for the RT-PCR reactions were as follows. 1st strand of eDNA 
synthesis: 1 cycle of 45 °C for 45 minutes to 94 °( for 2 minutes. Once the temperature 
reached 94 °C, the machine was paused for addition of the Tfl polymerase. The tubes 
were promptly spun down and placed back into the machine where the cycle was 
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resumed at 94 °( for 2 minutes. Amplification: 40 cycles of 94 °( for 30 seconds to 60 °C 
for 1 minute to 68 °( for 2 minutes. Completion: 1 cycle of 68 °( for 7 minutes. The 
machine then dropped to 4 °( where it remained until the tubes were removed for 
agarose gel electrophoresis. 
Agarose Gel Electrophoresis 
An agarose gel electrophoretic analysis was conducted using a 4% agarose gel in 
a lX TBE (89 mM Tris (pH 7.6), 89 mM Boric acid, 2 mM EDTA) buffer with the addition 
of Ethidium Bromide at a ratio of 5 lll/500mi1X TBE. Fifteen microliters of each RT-PCR 
sample was placed in a new PCR tube w ith the addition of 2 Ill of lOX loading buffer 
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(65% (w/v) Sucrose, 10 mM Tris-HCI (pH 7.5), 10 mM EDTA, 0.3% (w/v) Bromophenol 
Blue). Nine microliters of this solution was loaded into t he gel. For the ladder sample, 2 
Ill of 100bp Promega ladder was placed in a fresh PCR tube with 2 Ill lOX loading buffer 
and 6 Ill of 1X TBE. Nine microliters of this sample was loaded in the same manner. The 
gels ran at 62 volts for approximately 4 hours. Using a Biorad Gel imaging machine and 
Gel Doc'M XR software, the gels w ere visualized under UV light. 
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RESULTS/DISCUSSION 
Due to difficulties with the treated mouse embryos, there were no results found 
on the effects of DPH on Polo mRNA expression. Although these results were not 
obtained, two of the three goals of this study were still met. Primers were designed 
properly to amplify the Pol o mRNA. Optimization experiments were also successfully 
completed in both mouse liver and embryo samples. 
Pol 6 Primer optimization in Liver Tissue 
The optimization of the Pol o primer concentration was first done using a mouse 
liver sample. The proper band size for these primers was approximately 263 bp in 
length. The primer concentration can determine how much mRNA is amplified as well as 
how much background amplification occurs. The goal was to get the most liver Pol o 
mRNA amplification with the least amount of background amplification. The results of 
this experiment showed that 0.125mM of the primers gave the best amplification with 
the least amount of background amplification as seen in Figure 5, lane 3. The 
background amplification was likely the result of primer dimers. 
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500 
300 
200 
100 
Figure 5: Effect of primer 
concentration on Pol 8 mRNA 
expression in Mouse Liver. 1. 100bp 
ladder, 2. Negative control, 3. 0.125 
mM Pol 8 primers, 4. 0.25 mM Pol 8 
primers, 5. 0.5 mM Pol 8 primers 
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Magnesium Sulfate Concentration Optimization in Liver Tissue 
The other important concentration to optimize is the magnesium concentration 
since magnesium is essential for the binding of nucleotides to make eDNA and it 
determines how well the reverse transcriptase enzyme will work in making eDNA from 
the RNA template. The results showed that 2mM MgS04 was the concentration that 
provided the highest Pol o amplification with the least amount of background 
amplification as seen in Figure 6, lane 4. 
500 bp 
300 bp 
100 bp 
z 
Figure 6: Effect of MgS04 
concentration on Pol o mRNA 
expression in Mouse Liver. 1. l OObp 
ladder, 2. Negative control, 3. 1 mM MgS04, 4 . 
2 mM MgS04, 5. 3 mM MgS04 
263 bp 
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GAPDH & Pol 6 Primer Concentration Optimization in Liver Tissue 
For a positive control to ensure the PCR reaction was working properly and the 
bands being used to determine Pol 6 expression were not just coincidentally sized DNA 
contaminants, GAPDH primers were optimized alongside the Pol 6 primers. As seen in 
Figure 7, lane 4, GAPDH and the Pol 6 primers produced DNA bands very similar in size. 
These experiments could not be properly interpreted with this similarity in band size, so 
the primers were optimized separately to make use of the GAPDH positive control 
without making the interpretation of the Pol 6 mRNA expression impossible. 
2 3 4 5 6 
300bp -
200bp -
lOObp -
Figure 7: Effect of primer 
concentration on Pol 6 mRNA/ 
GAPDH expression in Mouse Liver. 1. 
lOObp ladder, 2. Negative control, 3. 1.25 mM 
Pol 6, 4. 1.125 mM GAPDH, 5. Pol 6 primers & 
GAPDH, 6. Pol6 primers & GAPDH wfo AMV-
RT 
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Pol 6 Primer Optimization in NaOH treated 2-cell Gl Embryos 
Figure 8 shows the results of optimizing the Polo primers separately in 2-cell 
stageS phase NaOH vehicle embryos with the optimized magnesium concentration of 
2mM. 
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• 
500 bp 
300bp 
200bp -
100 bp 
Figure 8: Effect of Pol 6 primer 
concentration on Pol 6 mRNA 
expression in NaOH treated Embryos. 
1. 100 bp ladder, 2. Negative control, 3. 
0.125 mM Polo primers, 4. 0.25 mM Polo 
primers, 5. 0.5 mM Pol 6 primers 
- 263bp 
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Future Improvements 
There were several issues with the proper execution of this experiment that 
could have led to error causing the issues obtaining viable results. The embryos used in 
this experiment were isolated between 4 and 6 months before they were used for the 
PCR procedures. This time gap could have allowed for degradation of the RNA. The 
freeze-thaw cycles help lyse the cell membranes to release the RNA into solution, so not 
enough quick cycles of this may have allowed RNA to remain blocked by the membrane 
from being present in the reaction. Another issue was with the electrophoresis buffer, 
which contained a much smaller amount of the ethidium bromide dye used to mark the 
bands for imaging than what has been used for previous experiments like this. So 
improvements would include using the isolated embryos soon after isolating them, 
increasing the ethidium bromide concentration in the electrophoresis buffer, and 
running the isolated embryos through one or two more freeze-thaw cycles. To improve 
upon this experiment to successfully determine the effects of Dilantin on Pol D mRNA 
expression, improvements in the isolation of embryos, the lysing of those embryos via 
freeze-thaw cycles, and the electrophoresis buffer may all aid in obtaining definitive 
results. 
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Conclusion 
The presence of bands that are approximately 263bp with a low amount of 
background amplification indicates the successful amplification of the target gene, 
POLD-1. The primers were therefore designed and optimized properly. The resulting 
optimal Pol D primer concentration was 0.25 mM and the optimal magnesium sulfate 
concentration was 2 mM. 
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